152 related articles for article (PubMed ID: 37177792)
21. Experimental production of hemorrhagic enterotoxemia by Clostridium perfringens type C in maturing lambs.
Niilo L
Can J Vet Res; 1986 Jan; 50(1):32-5. PubMed ID: 2874878
[TBL] [Abstract][Full Text] [Related]
22. Epsilon toxin: a fascinating pore-forming toxin.
Popoff MR
FEBS J; 2011 Dec; 278(23):4602-15. PubMed ID: 21535407
[TBL] [Abstract][Full Text] [Related]
23. Epsilon toxin from Clostridium perfringens induces toxic effects on skin tissues and HaCaT and human epidermal keratinocytes.
Geng Z; Kang L; Huang J; Gao S; Wang J; Yuan Y; Li Y; Wang J; Xin W
Toxicon; 2021 Jul; 198():102-110. PubMed ID: 33965432
[TBL] [Abstract][Full Text] [Related]
24. Ulcerative enterocolitis in two goats associated with enterotoxin- and beta2 toxin-positive Clostridium perfringens type D.
Uzal FA; Fisher DJ; Saputo J; Sayeed S; McClane BA; Songer G; Trinh HT; Fernandez Miyakawa ME; Gard S
J Vet Diagn Invest; 2008 Sep; 20(5):668-72. PubMed ID: 18776108
[TBL] [Abstract][Full Text] [Related]
25. Detection of alpha- and epsilon-toxigenic Clostridium perfringens type D in sheep and goats using a DNA amplification technique (PCR).
Miserez R; Frey J; Buogo C; Capaul S; Tontis A; Burnens A; Nicolet J
Lett Appl Microbiol; 1998 May; 26(5):382-6. PubMed ID: 9674169
[TBL] [Abstract][Full Text] [Related]
26. Correlation between in vitro cytotoxicity and in vivo lethal activity in mice of epsilon toxin mutants from Clostridium perfringens.
Dorca-Arévalo J; Pauillac S; Díaz-Hidalgo L; Martín-Satué M; Popoff MR; Blasi J
PLoS One; 2014; 9(7):e102417. PubMed ID: 25013927
[TBL] [Abstract][Full Text] [Related]
27. Recombinant unpurified rETX
Peng X; Li X; Peng G; Feng L; Jiang Y; Luo Y
J Vet Med Sci; 2021 Apr; 83(3):441-446. PubMed ID: 33551442
[TBL] [Abstract][Full Text] [Related]
28. A low-toxic site-directed mutant of Clostridium perfringens ε-toxin as a potential candidate vaccine against enterotoxemia.
Li Q; Xin W; Gao S; Kang L; Wang J
Hum Vaccin Immunother; 2013 Nov; 9(11):2386-92. PubMed ID: 23835363
[TBL] [Abstract][Full Text] [Related]
29.
Kumar S; Behera SK; Gururaj K; Chaurasia A; Murmu S; Prabha R; Angadi UB; Pawaiya RS; Rai A
J Biomol Struct Dyn; 2024 Mar; 42(5):2257-2269. PubMed ID: 37129165
[TBL] [Abstract][Full Text] [Related]
30. Phenotypic detection and genotyping of
Alsaab F; Wahdan A; Saeed EMA
Vet World; 2021 Mar; 14(3):578-584. PubMed ID: 33935400
[TBL] [Abstract][Full Text] [Related]
31. Development and application of an oral challenge mouse model for studying Clostridium perfringens type D infection.
Fernandez-Miyakawa ME; Sayeed S; Fisher DJ; Poon R; Adams V; Rood JI; McClane BA; Saputo J; Uzal FA
Infect Immun; 2007 Sep; 75(9):4282-8. PubMed ID: 17562765
[TBL] [Abstract][Full Text] [Related]
32. Diagnosis of Clostridium perfringens intestinal infections in sheep and goats.
Uzal FA; Songer JG
J Vet Diagn Invest; 2008 May; 20(3):253-65. PubMed ID: 18460610
[TBL] [Abstract][Full Text] [Related]
33. The VirS/VirR two-component system regulates the anaerobic cytotoxicity, intestinal pathogenicity, and enterotoxemic lethality of Clostridium perfringens type C isolate CN3685.
Ma M; Vidal J; Saputo J; McClane BA; Uzal F
mBio; 2011 Jan; 2(1):e00338-10. PubMed ID: 21264065
[TBL] [Abstract][Full Text] [Related]
34. CodY is a global regulator of virulence-associated properties for Clostridium perfringens type D strain CN3718.
Li J; Ma M; Sarker MR; McClane BA
mBio; 2013 Oct; 4(5):e00770-13. PubMed ID: 24105766
[TBL] [Abstract][Full Text] [Related]
35. A non-toxic recombinant bivalent chimeric protein rETX
Du J; Liu B; Wang T; Zhu Z; Yin C; Luo Y; Liu Y; Chen X
Vaccine; 2023 Feb; 41(6):1232-1238. PubMed ID: 36635138
[TBL] [Abstract][Full Text] [Related]
36. Isolation and Molecular Characterization of
Alimolaei M; Shamsaddini Bafti M
Arch Razi Inst; 2023 Jun; 78(3):1159-1168. PubMed ID: 38028824
[TBL] [Abstract][Full Text] [Related]
37. Potency against enterotoxemia of a recombinant Clostridium perfringens type D epsilon toxoid in ruminants.
Lobato FC; Lima CG; Assis RA; Pires PS; Silva RO; Salvarani FM; Carmo AO; Contigli C; Kalapothakis E
Vaccine; 2010 Aug; 28(38):6125-7. PubMed ID: 20670910
[TBL] [Abstract][Full Text] [Related]
38. Prevalence, Genotypic and Phenotypic Characterization and Antibiotic Resistance Profile of
Mohiuddin M; Iqbal Z; Siddique A; Liao S; Salamat MKF; Qi N; Din AM; Sun M
Toxins (Basel); 2020 Oct; 12(10):. PubMed ID: 33066416
[No Abstract] [Full Text] [Related]
39. [Ovine enterotoxemia caused by Cl. perfringens type A].
Volkova AA; Dzhamgyrchieva TD
Veterinariia; 1976 Dec; (12):38-9. PubMed ID: 191981
[No Abstract] [Full Text] [Related]
40. Reevaluation of whether a Functional Agr-like Quorum-Sensing System Is Necessary for Production of Wild-Type Levels of Epsilon-Toxin by Clostridium perfringens Type D Strains.
Mehdizadeh Gohari I; Li J; Rood JI; McClane BA
mBio; 2022 Apr; 13(2):e0049622. PubMed ID: 35319233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
